Spin-Off Research analyst Joseph Cornell downgraded Concentra (CON) to Sell from Hold with a $21 price target
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CON:
- Concentra announces completion of spin-off from Select Medical
- Select Medical downgraded to Hold at Benchmark after Concentra spin
- Concentra to replace Myers Industries in S&P 600 at open on 11/27
- Select Medical announces distribution ratio for special stock distribution
- Concentra opens new medical center in Texas